This topic contains a solution. Click here to go to the answer

Author Question: The requirements for the binomial distribution are _________. a. a series of N trials b. only ... (Read 74 times)

dalyningkenk

  • Hero Member
  • *****
  • Posts: 598
The requirements for the binomial distribution are _________.
 
  a. a series of N trials
  b. only two possible outcomes on each trial
  c. the outcomes on each trial are mutually exclusive
  d. there is independence between trials
  e. all of these

Question 2

The binomial distribution _________.
 
  a. is a probability distribution
  b. gives each possible outcome of N trials
  c. gives the probability of getting each outcome
  d. all of these



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

briseldagonzales

  • Sr. Member
  • ****
  • Posts: 303
Answer to Question 1

E

Answer to Question 2

D




dalyningkenk

  • Member
  • Posts: 598
Reply 2 on: Jun 19, 2018
Thanks for the timely response, appreciate it


blakcmamba

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library